Citations

Clear

98 citation(s) found for "Sharaf, I".

Hyoid Position and Aging: A Comprehensive Analysis Using AI-assisted Segmentation of 282 Computed Tomography Scans
Pazelli, Alexandre Meira, Shehab, Abdallah A. , Rames, Jess D. , Hussein, Sara , Bustos, Samyd S. , Sears, Victoria A. , Wentworth, Adam, Morris, Jonathan M. , Sharaf, Basel , Meira Pazelli, Alexandre, Hussein, Sara M., Sharaf, Basel A, Bustos, S S , Sharaf, Basel A

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | September 6, 2024 | Volume: 12 | Issue: 9 | Pages: e6119

10.1097/gox.0000000000006119 | PMID 39247578 Get It

Background: With neck, aging the cervicomental angle becomes obtuse and may be influenced by hyoid bone aging. An understanding of hyoid position changes with aging will further our understanding of its role in neck contour changes. Methods: A 3D volumetric reconstruction of 282 neck computed tomography scans was performed. The cohort was categorized into three groups based on age: 20 years or older and younger than 40 years, 40 years or older and younger than 60 years, and 60 years or older and younger than 80 years. The vertical and horizontal hyoid distances in relation to the mandible were calculated for each patient. Results: A total of 282 patients (153 women, 129 men) were included in the cohort. The age groups were evenly distributed in men and women. Mean hyoid vertical and horizontal distances differed between women and men in all age groups. There was a significant difference in the hyoid vertical distance between 20–39 years old to 40–59 years old in men (P < 0.01), and 20–39 years old to 60–79 years old in both genders (women P = 0.005, men P < 0.01). Hyoid horizontal distance was not affected by age and sex (age and sex: P > 0.05), but rather by body mass index (BMI). Every 5 BMI points corresponded to a forward movement of 2 mm. Conclusions: As individuals age, the hyoid bone descends in both sexes, and an increase in BMI is associated with forward movement. Additional studies are needed to assess the correlation of the hyoid position between upright and supine positions.
Procurement Trends, Indications, and Outcomes of Heart–Lung Transplantation in the Contemporary Era
Treffalls, John A. , Brennan, Zachary , Chen, Qiudong , Pennington, Kelly M. , Spencer, Philip J. , Villavicencio, Mauricio A. , Daly, Richard C. , Saddoughi, Sahar A. , Griffeth, Elaine M. , Chen, Qiudong , Pennington, Kelly , Spencer, Philip J , Bilgili, Ahmet , Sharaf, Omar M.

Mayo Clinic

Clinical Transplantation | September 3, 2024 | Volume: 38 | Issue: 9 | Pages: No page available

10.1111/ctr.15447 | PMID 39225590 Get It

ABSTRACTBackgroundEvolving trends in organ procurement and technological innovation prompted an investigation into recent trends, indications, and outcomes following combined heart–lung transplantation (HLTx).MethodsThe United Network for Organ Sharing database was queried for all adult (≥18 years) HLTx performed between July 1, 2013 and June 30, 2023. Patients with previous transplants were excluded. The primary endpoint was the effect of donor, recipient, and transplantation characteristics on 1‐ and 5‐year survival. Secondary analyses included a comparison of HLTx at high‐ and low‐volume centers, an assessment of HLTx following donation after circulatory death (DCD), and an evaluation of HLTx volume over time. Cox proportional‐hazards models were used to assess factors associated with mortality. Temporal trends were evaluated with linear regression.ResultsAfter exclusions, 319 patients were analyzed, of whom 5 (1.6%) were DCD. HLTx volume increased from 2013 to 2023 (p < 0.001). One‐ and 5‐year survival following HLTx was 84.0% and 59.5%, respectively. One‐year survival was higher for patients undergoing HLTx at a high‐volume center (88.3% vs. 77.9%; p = 0.012). After risk adjustment, extracorporeal membrane oxygenation support 72 h posttransplant and predischarge dialysis were associated with increased 1‐year mortality (HR = 3.19, 95% CI = 1.86–5.49 and HR = 3.47, 95% CI = 2.17–5.54, respectively) and 5‐year mortality (HR = 2.901, 95% CI = 1.679–5.011 and HR = 3.327, 95% CI = 2.085–5.311, respectively), but HLTx at a high‐volume center was not associated with either.ConclusionsHLTx volume has resurged, with DCD HLTx emerging as a viable procurement strategy. Factors associated with 1‐ and 5‐year survival may be used to guide postoperative management following HLTx.
Population-Level Identification of Patients With Lynch Syndrome for Clinical Care, Quality Improvement, and Research
Sharaf, Ravi , Udaltsova, Natalia , Li, Dan , Pai, Rish K. , Sinha, Soham , Li, Zixuan , Corley, Douglas A. , Sharaf, Ravi N , Sinha, Soham

Mayo Clinic

JCO Clinical Cancer Informatics | June 5, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/cci.23.00157 | PMID 38838280 Get It

PURPOSE Identification of those at risk of hereditary cancer syndromes using electronic health record (EHR) data sources is important for clinical care, quality improvement, and research. We describe diagnostic processes, previously seldom reported, for a common hereditary cancer syndrome, Lynch syndrome (LS), using EHR data within a community-based, multicenter, demographically diverse health system. METHODS Within a retrospective cohort enrolled between 2015 and 2020 at Kaiser Permanente Northern California, we assessed electronic diagnostic domains for LS including (1) family history of LS-associated cancer; (2) personal history of LS-associated cancer; (3) LS screening via mismatch repair deficiency (MMRD) testing of newly diagnosed malignancy; (4) germline genetic test results; and (5) clinician-entered diagnostic codes for LS. We calculated proportions and overlap for each diagnostic domain descriptively. RESULTS Among 5.8 million individuals, (1) 28,492 (0.49%) had a family history of LS-associated cancer of whom 3,635 (13%) underwent genetic testing; (2) 100,046 (1.7%) had a personal history of a LS-associated cancer; and (3) 8,711 (0.1%) were diagnosed with colorectal cancer of whom 7,533 (86%) underwent MMRD screening and of the positive screens (486), 130 (27%) underwent germline testing. One thousand seven hundred and fifty-seven (0.03%) were diagnosed with endometrial cancer of whom 1,613 (92%) underwent MMRD screening and of the 195 who screened positive, 55 (28%) underwent genetic testing. (4) 30,790 (0.05%) had LS germline genetic testing with 707 (0.01%) testing positive; and (5) 1,273 (0.02%) had a clinician-entered diagnosis of LS. CONCLUSION It is feasible to electronically characterize the diagnostic processes of LS. No single data source comprehensively identifies all LS carriers. There is underutilization of LS genetic testing for those eligible and underdiagnosis of LS. Our work informs similar efforts in other settings for hereditary cancer syndromes.
QSAAPS02. Facial Skeleton Aging Pattern: AI-assisted Statistical Shape Modeling And Volumetric Analysis In The White Population
Hussein, Sara , Rames, Jess D. , Pazelli, Alexandre Meira, Abushehab, Abdallah, Wentworth, Adam, Sears, Victoria A. , Morris, Jonathan M. , Sharaf, Basel

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 1-1

10.1097/01.gox.0001017988.11406.83 Get It

Effect of Facial Feminization Surgery (FFS) on Eyelid Anatomic Features
Luong, Hanna N. , Liu, Alice , Sharaf, Basel , Bite, Uldis, Wagner, Lilly H. , Liu, Alice S, Sharaf, Basel A, Sharaf, Basel A

Mayo Clinic

Facial Plastic Surgery | April 27, 2024 | Volume: 41 | Issue: 03 | Pages: 307-312

10.1055/a-2315-7612 | PMID 38677276 Get It

Abstract Facial feminization surgery (FFS) improves gender dysphoria. The brows and eyes are crucial in perceived gender, yet brow and eyelid surgeries are relatively underutilized. This study aimed to determine rates of brow and eyelid surgeries as part of FFS and characterize pre- and postoperative periocular features. We conducted a retrospective review to identify all patients with the diagnosis of gender dysphoria who underwent FFS at a single academic institution from 2019 to 2022. Thirty-four patients comprising 38 surgical cases were included. Twelve (35%) eyelid surgeries and 27 (79%) brow lifts were performed. Baseline eyelid measurements did not differ between brow lift and nonbrow lift cases. Those undergoing brow lift and eyelid surgery were older in age (p = 0.022), had a higher rate of negative canthal tilt (p = 0.050), and smaller baseline margin-reflex distance 1 (p = 0.014) than patients who had brow lift alone. Brow lift increased tarsal platform show (p ≤ 0.001) and lash-to-brow distance (p ≤ 0.001), and upper blepharoplasty increased tarsal platform show (p = 0.01). Rates of brow lift are high at our institution, and patients are appropriately selected for eyelid surgery in FFS. Brow lift and upper blepharoplasty can feminize anatomical features when using standards described for cisgender cohorts. The impact of periocular features on gender perception in transgender patients warrants further study.
Feminizing Gender Affirming Breast Surgery: Procedural Outcomes at a Single Academic Institution
Figueroa, Nicole Sanchez, Fahradyan, Vahe , Tran, Nho V. , Martinez‐Jorge, Jorys, Figueroa, Nicole Gabriela Sanchez , Fahradyan, Vahe , Sanchez Figueroa, Nicole Gabriela , Kuruoglu, Doga , Sharaf, Basel

Mayo Clinic

Aesthetic Surgery Journal Open Forum | April 26, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/asjof/ojae032 | PMID 38813116 Get It

Abstract Background Implant-based breast augmentation is a gold standard procedure for transfeminine patients to create a more feminine-appearing chest. In many cases, ancillary procedures are performed simultaneously to achieve an optimal aesthetic result. Objectives To determine the clinical outcomes of patients undergoing feminizing gender-affirming breast surgery in a single academic institution. Methods A retrospective electronic chart review of feminizing gender-affirming breast surgery patients at Mayo Clinic, Rochester from 2017 to 2022 was conducted. Patients demographics and surgical outcomes were gathered. A survival analysis was performed to obtain the time-to-event complication rate. Results Over 5 years, 46 patients (92 breasts) were included. The mean age was 39 years (SD ±15), and most had an above-normal Body Mass Index (58.7%). Thirty (65%) had previous gender-affirming surgeries. The mean implant volume was 289 ml (SD ±95; 140 - 520). Most implants were placed in a subglandular plane (81%) with an inframammary fold incision (91.3%). All implants used were smooth round cohesive silicone gel implants. Ancillary procedures were performed in thirty-two patients (69.57%). Eight patients presented complications (4 major vs 4 minor) in a median postoperative follow-up of 372 vs 392 days; at 1-month follow-up, the probability of a complication to have occurred is 2.17% (95% CI: 0–6.3%) vs 5% (95% CI: 0–11.5%) and at 1 year is 10.21% (95% CI: 0–20.9%) vs 12.5% (95% CI: 0–23.4%) ​which remain the same up to 4 years. Conclusions Breast augmentation with implants is a safe procedure to achieve feminization of the breast with a low rate of complications.
Clinical evaluation of a stereotactic system for single-stage deep brain stimulation surgery under general anesthesia: technical note
Scheitler, Kristen M. , Rusheen, Aaron E. , Goyal, Abhinav , Hong, Sukwoo , Osman, Gamaleldin , Sharaf, Basel , Klassen, Bryan T. , Miller, Kai J. , Shin, Hojin , Lee, Kendall H. , Sharaf, Basel A , Yuen, Jason , Grewal, Sanjeet S. , Oh, Yoonbae

Mayo Clinic

Journal of Neurosurgery | March 16, 2024 | Volume: 141 | Issue: 2 | Pages: 406-411

10.3171/2024.1.jns232563 | PMID 38489816 Get It

OBJECTIVE Conventional frame-based stereotactic systems have circumferential base frames, often necessitating deep brain stimulation (DBS) surgery in two stages: intracranial electrode insertion followed by surgical re-preparation and pulse generator implantation. Some patients do not tolerate awake surgery, underscoring the need for a safe alternative for asleep DBS surgery. A frame-based stereotactic system with a skull-mounted "key" in lieu of a circumferential base frame received US FDA clearance. The authors describe the system’s application for single-stage, asleep DBS surgery in 8 patients at their institution and review its workflow and technical considerations. METHODS Eight patients underwent DBS lead insertion and IPG implantation in a single surgical preparation under general anesthesia using the system. Postoperative CT imaging confirmed lead placement. RESULTS Eight patients underwent implantation of 15 total leads targeting the ventral intermediate nucleus (4 patients), globus pallidus internus (GPi; 3 patients), and subthalamic nucleus (STN; 1 patient). Intraoperative microelectrode recording was conducted for GPi and STN targets. Postoperative CT imaging revealed a mean ± SD radial error of 1.24 ± 0.45 mm (n = 15 leads), without surgical complications. CONCLUSIONS The stereotactic system facilitated safe and effective asleep, single-stage DBS surgery, maintaining traditional lead accuracy standards.
Cardiac implantable electronic devices in female patients: Esthetic, breast implant, and anatomic considerations
Salinas, Cristina A., Mulpuru, Siva K. , Asirvatham, Samuel J. , Sharaf, Basel , Ezzeddine, Fatima , Mulpuru, Siva K , Asirvatham, Samuel J , Sharaf, Basel A, Sharaf, Basel A , Ezzeddine, Fatima M.

Mayo Clinic

Journal of Cardiovascular Electrophysiology | February 15, 2024 | Volume: 35 | Issue: 4 | Pages: 747-761

10.1111/jce.16196 | PMID 38361241 Get It

Abstract Introduction The implantation of a cardiac implantable electronic device (CIED) can have esthetic and psychological consequences on patients. We explore a heart team model for care coordination and discuss esthetic approaches for improved cosmetic outcomes in patients undergoing (CIED)‐related procedures or de novo implantation. Methods Patients undergoing CIED surgery for approved indications between June 2015 and June 2022 were identified. Patients were included when surgical care was provided by a collaborative relationship between the primary electrophysiologist and the plastic surgeon. Patient demographics, details of the surgical procedure, information on breast implants, complications, and outcomes related to cosmesis were recorded. Results Twenty‐two female patients were included in this study. The mean age was 50.2 ± 18.2 years. The mean follow‐up duration was 2.2 ± 5.5 months. The top two indications for the procedure included CIED generator change ( n = 9, 41%) and implantable cardioverter‐defibrillator (ICD) implantation ( n = 7, 32%). The most common reasons for involving plastic surgery in the procedure included surgery near breast implants ( n = 10, 45%) and device displacement or discomfort ( n = 8, 36%). CIED pocket position was prepectoral in 10 cases (45%), subpectoral in 11 patients (50%), and intramuscular in one patient (4.5%). The majority of the patients (20, 91%) had cosmetically acceptable results postprocedure. One patient (4.5%) had breast asymmetry on the CIED side, and another continued to have skin erosion over the CIED and leads. Conclusion A heart team approach incorporating the expertize of cardiac electrophysiology and plastic surgery is essential for providing optimal care for patients with breast implants and patients requesting esthetic appeal.
Eyelid and Brow Rejuvenation: Technical Pearls and Outcomes of Upper Blepharoplasty with or without Ptosis Correction and Brow Lift
Rodriguez, Liset Falcon , Salinas, Cristina A., Bite, Uldis, Sharaf, Basel , Falcon Rodriguez, Liset, Liu, Alice , Sharaf, Basel A , Kuruoglu, Doga , Wagner, Lilly H. , Bradley, Elizabeth A. , Mardini, Samir

Mayo Clinic

Plastic & Reconstructive Surgery | February 5, 2024 | Volume: 154 | Issue: 6 | Pages: 1199-1207

10.1097/prs.0000000000011324 | PMID 38315110 Get It

Background: Eyelid ptosis may present with upper lid dermatochalasis and brow ptosis. When indicated, ptosis correction (PC) is advocated during upper blepharoplasty (UB). In this study, the authors aimed to report their outcomes following UB and PC. Methods: A retrospective review of patients who underwent UB from November of 2018 to March of 2020 was performed. Patient demographics, clinical characteristics, and revisions were recorded. Cox regression was performed to assess predictors of revision. Results: Overall, 278 patients with 533 UB were included. The mean patient age was 67.3 years. The mean follow-up was 8.3 months. In 169 cases (31.7%), a brow lift was performed. UB and PC were performed in 109 cases (20.5%), of which 60 (55%) involved Müller muscle conjunctival resection and 49 (45%) were levator repairs. New dry eye symptoms lasting 3 months or longer occurred in 4 cases (0.8%), all of which resolved. The revision rate was 3.8% after UB (residual skin [ n = 11], hypertrophic scar [ n = 4], and Herring law–related ptosis [ n = 1]) versus 9.2% after UB and PC (overcorrection [ n = 4], residual skin [ n = 4], and asymmetry [ n = 2]). Multivariable analysis demonstrated increased revision rates after UB and PC ( P = 0.008). There was no difference in revision rates between different techniques of PC. Conclusions: In this study of 278 patients presenting for dermatochalasis, up to 21% of cases required ptosis correction in addition to upper blepharoplasty. Ptosis correction is a safe procedure when combined with upper blepharoplasty, regardless of technique used. The revision rate in our series was 9.2% after the combined procedure, which is greater than the revision rate of upper blepharoplasty only but comparable to that in the literature. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
Revisiting Breast Reduction Insurance Coverage: How the Schnur Scale Discriminates against Women Based on Body Habitus
Ochoa, Pablo , Salinas, Cristina A., Zheng, Eugene E., Martinez‐Jorge, Jorys, Harless, Christin A., Vijayasekaran, Aparna , Sharaf, Basel , Ochoa, Pablo C, Sharaf, Basel A, Sharaf, Basel A , Zheng, Eugene E.

Mayo Clinic

Plastic & Reconstructive Surgery | January 9, 2024 | Volume: 154 | Issue: 4 | Pages: 699-705

10.1097/prs.0000000000011287 | PMID 38194607 Get It

Background: The Schnur scale used body surface area (BSA) to determine the amount of breast tissue resection in reduction mammaplasty, resulting in a greater requirement of breast weight removal in patients with larger BSA. The authors aimed to demonstrate BSA variance among women with similar mastectomy weights and the range of mastectomy weights among women with comparable BSAs. Methods: A retrospective chart review of patients who underwent mastectomy from October of 2021 to June of 2022 was performed. Patients were included if they underwent skin-sparing or nipple-sparing mastectomy with a minimum specimen weight of 700 g. Patient’s BSA, body mass index (BMI), mastectomy weight, and Schnur weight requirement (SWR) were collected. Results: A total of 130 patients (194 breasts) were included. There was significant variance in mean BSA, BMI, SWR, and SWR-to–mastectomy weight ratio among women with similar mastectomy weights. BSA varied by as much as 0.82 units, BMI varied by as much as 32 kg/m2, and SWR varied by as much as 1365 g within the same mastectomy weight group. There was also significant variance in mastectomy weights among women with comparable BSA, especially in BSA groups greater than 2.20, with the greatest range in mastectomy weights being 1684 g. Conclusions: Analysis of mastectomy patients showed no predictable relationship between BSA and breast weight. There was significant variance in the BSA of patients with similar breast weights, and conversely in breast weights of patients with comparable BSA. Therefore, strict adherence to the Schnur weight requirement can prevent patients with macromastia from receiving breast reductions.